Pros and Cons of Ampio Pharmaceuticals Inc. in the next few years
Pros
?
M***** P*******
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ampio Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ampio Pharmaceuticals Inc. | - | - | - | - | - | - | - |
| Protara Therapeutics Inc. | -6.630% | 2.156% | -7.593% | 25.819% | -0.135% | 64.963% | -63.789% |
| India Globalization Capital | 5.000% | 16.964% | 9.167% | 9.167% | 10.084% | -3.676% | -81.627% |
| Gensight Biologics SA | -3.620% | -0.810% | -20.795% | -64.067% | -24.427% | -96.200% | -98.843% |
Comments
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat